Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - STERIS plcste09302017ex321.htm
EX-31.2 - EXHIBIT 31.2 - STERIS plcste09302017ex312.htm
EX-31.1 - EXHIBIT 31.1 - STERIS plcste09302017ex311.htm
EX-10.6 - EXHIBIT 10.6 - STERIS plcste09302017ex106.htm
EX-10.5 - EXHIBIT 10.5 - STERIS plcste09302017ex105.htm
EX-10.4 - EXHIBIT 10.4 - STERIS plcste09302017ex104.htm
EX-10.3 - EXHIBIT 10.3 - STERIS plcste09302017ex103.htm
EX-10.2 - EXHIBIT 10.2 - STERIS plcste09302017ex102.htm
EX-10.1 - EXHIBIT 10.1 - STERIS plcste09302017ex101.htm
10-Q - 10-Q - STERIS plcste0930201710-q.htm


Exhibit 15.1

LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION


Board of Directors and Shareholders
STERIS plc
 
We are aware of the incorporation by reference in the following STERIS plc Registration Statements of our review report, dated November 7, 2017, relating to the unaudited consolidated interim financial statements of STERIS plc and subsidiaries, included in its Form 10-Q for the quarter ended September 30, 2017:
 
 
 
Registration
Number
 
Description
 
 
 
333-207721
Form S-8 Registration Statement – STERIS plc 2006 Long-Term Equity Incentive Plan, Assumed as Amended and Restated
 
 
333-207722
Form S-8 Registration Statement – STERIS Corporation 401(k) Plan
 
 
333-214491
Form S-8 Registration Statement – STERIS plc 2006 Long-Term Equity Incentive Plan
 
 
 
 


/s/ Ernst & Young LLP

Cleveland, Ohio
November 7, 2017